Port Erin Biopharma Investments Ltd Change of Adviser (2799V)
April 15 2016 - 2:00AM
UK Regulatory
TIDMPEBI
RNS Number : 2799V
Port Erin Biopharma Investments Ltd
15 April 2016
Port Erin Biopharma Investments Limited
("Port Erin" or the "Company")
Change of Adviser
The Board of Port Erin, the AIM quoted company focused on
investing in the biotechnology and biopharmaceutical sectors, is
pleased to announce the appointment of Northland Capital Partners
Limited as the Company's Nominated Adviser and Joint Broker with
immediate effect.
Enquiries
Port Erin Biopharma Investments +44(0) 1624
Limited 639396
Denham Eke
+44(0) 203
Northland Capital Partners Limited 861 6625
Nominated Adviser and Joint Broker
Matthew Johnson / David Hignell
/ Gerry Beaney (Corporate Finance)
John Howes / Rob Rees (Broking)
+44(0) 207
Peterhouse Corporate Finance Limited 469 0936
Joint Broker
Lucy Williams
This information is provided by RNS
The company news service from the London Stock Exchange
END
APPBLGDSBXBBGLS
(END) Dow Jones Newswires
April 15, 2016 02:00 ET (06:00 GMT)
Agronomics (LSE:ANIC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Agronomics (LSE:ANIC)
Historical Stock Chart
From Jul 2023 to Jul 2024